Evaluation of serum Spondin 2 levels in the different stages of Type 2 diabetic nephropathy (pages 721–726)
Serdar Kahvecioglu, Metin Guclu, Yasemin Ustundag, Cuma Bulent Gul, Ibrahim Dogan, Tuncay Dagel, Bennur Esen, Selin Akturk Esen, Huseyin Celik and Irfan Esen
Article first published online: 11 SEP 2015 | DOI: 10.1111/nep.12507
Summary at a Glance
This study highlights the challenges in developing better biomarkers for the assessment of disease progression in diabetic kidney disease. The cohort examines the role of serum spondin-2 as a marker of disease progression diabetic nephropathy.